Related references
Note: Only part of the references are listed.Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease
Koichi Kaikita et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Evaluation of the Total Thrombus-Formation System (T-TAS): application to human and mouse blood analysis
Rashid Al Ghaithi et al.
PLATELETS (2019)
Total Thrombus-formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Yu Oimatsu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Effect of ticagrelor versus prasugrel on platelet reactivity: a meta-analysis
Hengliang Zhang et al.
CORONARY ARTERY DISEASE (2017)
Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy
Y. Arima et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients With Diabetes
Dimitrios Alexopoulos et al.
DIABETES CARE (2013)
Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding
Udaya S. Tantry et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms (CYP2C19, ABCB1, PON1), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function
Andrew L. Frelinger et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions
Kazuya Hosokawa et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals
Yusuke Yamaguchi et al.
THROMBOSIS RESEARCH (2013)
Induction of functional platelets from mouse and human fibroblasts by p45NF-E2/Maf
Yukako Ono et al.
BLOOD (2012)
Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and anti-factor IXa-treated human blood
S. Ogawa et al.
HAEMOPHILIA (2012)
Ticagrelor Versus Prasugrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity Following Percutaneous Coronary Intervention A Pharmacodynamic Study
Dimitrios Alexopoulos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions
K. Hosokawa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions
Satoru Ogawa et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Ticagrelor: The First Reversibly Binding Oral P2Y(12) Receptor Antagonist
Steen Husted et al.
CARDIOVASCULAR THERAPEUTICS (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Clinical profile of prasugrel, a novel thienopyridine
Dominick J. Angiolillo et al.
AMERICAN HEART JOURNAL (2008)
Prasugrel: A novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile
Joseph A. Jakubowski et al.
CARDIOVASCULAR DRUG REVIEWS (2007)
Share Paper
